Stability of Human Serum Albumin Loaded PLGA Nanoparticles for Protein Delivery Applications

Authors

  • Sri Vidawati
  • Silvia Barbosa
  • Pablo Taboada
  • Nadhifa P. Safira

DOI:

https://doi.org/10.14738/aivp.101.11724

Keywords:

Nanoparticles, PLGA, HSA.

Abstract

Poly(lactic-co-glycolic acid) (PLGA) is one of the most effectively developed biodegradable polymers. Biodegradable polymers based on PLGA are the most common materials used to encapsulate therapeutic agents. Protein-loaded PLGA nanoparticles are generally formulated by the double emulsion method. However, the main problems associated with this method are low encapsulation efficiency proteins and instability proteins. This study report the stability of encapsulate of Human Serum Albumin (HSA)-loaded PLGA nanoparticles for protein delivery applications.

References

Moghimi, SM., Hunter, ACH., Murray, JC., Pharm Rev. 53(2001)283-318.

Curtis, ASG., Wilkinson, C., Trends Biotech 19 (2001)97-101.

Panyam, J., Labhasetwar, V., Adv. Drug Del. Rev. 55(2003)329-47.

Yih, TC., Al-Fandi M., J Cell Biochem. 97(2006)1184-90.

Allen, TM., Cullis, PR., Science 303(2004)1818- 1822.

Soppimath, KS., Aminabhavi, TM., Kulkarni, AR., Rudzinski, WE., J. Control. Release 70(2001)1-20.

Panyam, J., Labhasetwar, V., Adv. Drug Deliv. Rev. 55(2003)329-347.

Jiang W, Gupta RK, Deshpande MC, Schwendeman SP. Adv Drug Deliv. Rev. 57(2005)391-410.

Fischer, S., Uetz-von Allmen, E., Waeckerle-Men, Y., Groettrup, M., Merkle, HP., Gander, B., Biomaterials 28(2007)994-1004.

Van de Weert, M., Hennink, WE., Jiskoot, W., Pharm Res 17(2000)1159-67.

Tamber, H., Johansen, P., Merkle, HP., Gander, B., Adv Drug Deliv. Rev. 57(2005)357-76.

Giteau, A., Venier-Julienne, MC., Marchal, S., Courthaudon, JL., Sergent, M., Montero-Menei, C., Verdier, JM., Benoit, JP., Eur. J. Pharm. Biopharm. 70(2008)127-136.

Cleland, JL., Powell, MF., Shire, SJ. Rev. Ther. Drug Carrier Syst. 10(1993)307-377.

Forbes, DC., Peppas, NA., J. Controlled Release 162(2012) 438-445.

Leader, B., Baca, QJ., Golan, DE., Protein therapeutics: a summary and pharmacological classification. Nat. Rev. Drug Discov. 7(2008)21-39.

Bilati, U., Alle´mann, E., Doelker, E., Eur. J. Pharm. Biopharm. 59(2005)375-388.

Bysell, H., Månsson, R., Hansson, P., Malmsten, M., Adv. Drug Deliv. Rev. 63(2011)1172-1185.

Mora-Huertasa, CE., Fessi, H., Elaissari, A., Int. J. Pharm. 385 (2010)113-142.

Vidawati, S., Barbosa, S., Taboada, P., Topete, A., Villar, E. and Mosquera, V. Advances in Biological Chemistry, 8(2018)91-100.

Vidawati, S., Barbosa, S., Taboada, P., Mosquera, V. Advances in Biological Chemistry, 9(2019)179-188.

Downloads

Published

2022-02-13

How to Cite

Vidawati, S., Barbosa, S., Taboada, P., & Safira, N. P. (2022). Stability of Human Serum Albumin Loaded PLGA Nanoparticles for Protein Delivery Applications. European Journal of Applied Sciences, 10(1), 366–370. https://doi.org/10.14738/aivp.101.11724